Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Breast Neoplasms 15 Prostatic Neoplasms 9 Colorectal Neoplasms 7 Ovarian Neoplasms 5 Endometrial Neoplasms 5 Colonic Neoplasms 5 Rectal Neoplasms 4 Colorectal Neoplasms, Hereditary Nonpolyposis 4 Pancreatic Neoplasms 3 Leukemia, Myeloid, Acute 3 Brain Neoplasms 3 Wilms Tumor 2 Urogenital Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplastic Syndromes, Hereditary 2 Neoplasms, Unknown Primary 2 Neoplasm Metastasis 2 Melanoma 2 Leukemia, Myelomonocytic, Acute 2 Leukemia, Monocytic, Acute 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Erythroblastic, Acute 2 Leukemia, Eosinophilic, Acute 2 Leukemia, Basophilic, Acute 2 Leukemia 2 Kidney Neoplasms 2 Hereditary Breast and Ovarian Cancer Syndrome 2 Hematologic Neoplasms 2 Head and Neck Neoplasms 2 Glioma 2

Interventions

pembrolizumab 185 Gemcitabine 170 Paclitaxel 152 Carboplatin 137 Bevacizumab 128 Surveys and Questionnaires 118 Cisplatin 115 Docetaxel 114 Blood Specimen Collection 110 Cyclophosphamide 109 Exercise 108 Nivolumab 98 Fluorouracil 90 Capecitabine 86 Dexamethasone 81 Radiotherapy 80 Irinotecan 74 Standard of Care 69 Pemetrexed 68 Oxaliplatin 68 Leucovorin 64 Drug Therapy 64 Cetuximab 60 Erlotinib Hydrochloride 56 Sorafenib 53 atezolizumab 52 Ipilimumab 51 Doxorubicin 50 trametinib 47 Interviews as Topic 47

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Genetic Testing × Clear all

NCT06008392 2026-04-07

INTERCEPTioN

Mayo Clinic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡